Recurrent respiratory papillomatosis (RRP) remains a challenging disease afflicting children
and adults alike, resulting in an estimated $120 million per year in United States healthcare …

Objective Despite recent advancement recurrent respiratory papillomatosis (RRP) remains a
rare but challenging benign airway neoplasm. In recent years there has been significant …

Background Despite the human papillomavirus (HPV) vaccine being a safe, effective cancer
prevention method, its uptake is suboptimal in the United States (US). Previous research has …

RRP is declining in incidence but remains a challenging disease to treat with great costs to
patients, families, and the healthcare system. As the disease continues to be better …

In Colombia, the uptake rate of the HPV vaccine dropped from 96.7% after its introduction in
2013 to 9% in 2020. To identify the behavioural components of HPV-vaccine hesitancy in …

Although some people within LGBTQ communities are at risk of developing some cancers at
higher rates than non‐LGBTQ people, there is limited evidence of the outcomes of targeted …

Introduction: Infection with certain types of human papillomavirus (HPV) can lead to cervical
cancer as well as other cancers in both men and women. However, the requirement for …